U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. BHP Holdings Inc. dba BioPure Healing Products - 597687 - 03/28/2022
  1. Warning Letters

CLOSEOUT LETTER

BHP Holdings Inc. dba BioPure Healing Products MARCS-CMS 597687 —

Delivery Method:
Overnight Delivery
Product:
Dietary Supplements
Food & Beverages
Recipient:
Recipient Name
Brandy D. Floyd
Recipient Title
Chief Executive Officer
BHP Holdings Inc. dba BioPure Healing Products

18538 142nd Avenue NE
Woodinville, WA 98072
United States

Issuing Office:
Division of Human and Animal Food Operations West VI

United States

Dear Ms. Floyd:

The Food and Drug Administration has completed evaluation of your firm’s corrective actions in response to our Warning Letter CMS 597687, dated June 17, 2020. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely,
/S/
Miriam R. Burbach
District Director
Program Division Director

Back to Top